In 1946 Parker first described a syndrome of periodic ataxia in 11 patients: in four patients the ataxia was familial and in the remaining seven, a manifestation of multiple sclerosis. Ihis was before it had been recognised that periodic attacks of dysarthria and ataxia (see Chapters 2 and 15; p. 242) are characteristic paroxysms caused by demyelinated pathways within pontine and brachium conjunctivum structures in multiple scIerosis (Andermann et a1. 1959; Harrison and McGill 1969; Osterman and Westerberg 1975) .
Familial periodic ataxia (without MS) is arare, disabling condition of autosomal dominant inheritance, but it is not a distinct clinical entity. Synonyms are autosomal dominant episodic ataxia (EA) or hereditary paroxysmal cerebellar ataxia. Family members have a similar c1inical syndrome; however, the syndrome varies considerably from family to family. Ihis suggests separate disorders that probably have distinct causes. At least two groups of disorders have been separated c1inically (Brunt and van Weerden 1990; Gancher and Nutt 1986; Griggs and Nutt 1995; Brandt and Strupp 1997): 1. episodic ataxia -type 1 (EA-l), which manifests without vertigo and is associated with "interictal" myokymia, and 2. episodic ataxia -type 2 (EA-2), which often manifests with vertigo and is associated with "interictal" nystagmus.
The diagnosis of EA-l and EA-2 is important, since they can be easily treated and are often mislabeled. EA-l and EA-2 have been identified to be channelopathies. EA-1 was found to be due to different heterozygous missense point mutations in a voltagegated (delayed rectifier) potassium channel gene (KCNA1/Kv1.1) found on chromosome 12p13 (Browne et al. 1994) in seven families, whereas EA-2 is caused by mutations of the cerebral P/Q type calcium channel a subunit gene CACNLlA4, localised on chromosome 19p (Vahedi et al. 1995; Browne et al. 1995) , which is highly expre sed in the cerebellum. Here too there were also good reasons to postulate an ion-channel gene defect, since all autosomal dominant (acetazolamide-responsive) episodic disorders -such as myotonias or dyskalemic periodic paraly es (McArdle, 1962; Ptacek et a1. 1994 ) -have been caused by mutations in ion-channel genes (Cannon 1996; Hudson et al. 1995; Griggs and Nutt 1995) . Clinically EA-l and EA-2 differ in duration of the attacks, provoking factors, associated findings, and progression of the "interictal" signs (Table 25 .1). As effective as acetazolamide is in preventing attacks, prospective studies still have to prove whether it can prevent progressive ataxia in EA-2 or even improve chronic cerebellar deficits. Ihe mode of action of acetazolamide involves the correction of an abnormally elevated pH level in the cerebellum (Bain et al. 1992 ). There are fascinating similarities between episodic ataxias and familial hemiplegic migraine and CADASIL (cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy), all of which have been localised on chromosome 19 (Dichgans et a1. 1996) . The three allelic disorders EA-2, familial hemiplegic migraine, and dominantly inherited late-onset spinocerebellar ataxia type 6 (SCA6) have overlapping clinical features (Jen et al. 1998) .
In summary, familial episodic ataxias are autosomal dominant, inherited disorders caused by defects of chromosome 12p or 19p; one has been identified to be a potassium-channel gene defect, the other a calcium-channel gene defect. Further studies are necessary to und erstand the triggers for the attacks (their various duration), the different involvement of cerebellar structures and the peripheral neuromuscular system, and the progressive cerebellar degeneration in some of the affected families.
The most relevant differential diagnoses for familial periodic ataxias (EA-l and EA-2) are paroxysmal dysarthria and ataxia in multiple scIerosis (p. 242), basilar migraine (p. 329), and their variants of benign paroxysmal vertigo in childhood and benign recurrent vertigo in adults. A positive family history and responsiveness to acetazolamide trongly upport the diagnosis (Table 25 .1).
A number of autosomal or x-linked recessive metabolic defects can also manifest with episodic ataxia. These include Hartnup di ease, pyruvate decarboxylase deficiency, pyruvate dehydrogenase deficiency, and maple syrup urine disease (Baron et al. 1956; Blass et al. 1971; Dancis et al. 1967; Farmer et al. 1973; Lonsdale et al. 1969 ), all ofwhich should be treated as entities clearly distinct from autosomal dominant EA-l and EA-2, which will be discussed here. Modified from Griggs and Nutt (1995) and Ophoff et al. (1996) .
The clinical syndromes
It is easy to distinguish the two major groups of autosomal dominant episodic ataxias by their characteristic clinical differences. The key symptoms of EA-l are short paroxysms of ataxia (mostly without vertigo) and "interictal" continuous motor unit activity similar to myokymia and neuromyotonia. EA-2 shows more heterogeneity among afflicted families. Key symptoms are Ion ger-lasting paroxysms of ataxia (mostlywith vertigo) and "interictal" pathological nystagmus.
As indicated in Table 25 .1, the differential diagnosis is based mainly on the duration of attacks (seconds to minutes for EA-l ; hours to days for EA-2), Vertigo provoking factors (startle, exercise for EA-l; stress, exercise for EA-2), and associated signs (myokymia in EA-l; nystagmus and cerebellar signs in EA-2) (Brunt and van Weerden 1990; Griggs and Nutt 1995) .
Episodic ataxia associated with "interictal" myokymia (type EA-') Seven families have been described (Van Dyke et al. 1975; Hanson et al. 1977; Gancher and Nutt 1986; Brunt and van Weerden 1990; Browne et al. 1994 Browne et al. , 1995 who have a syndrome combined with central and peripheral signs classified as EA-l but also resembling paroxysmal kinesigenic choreoathetosis, myokymia, and neuromyotonia. Brunt and van Weerden (1990) have carefully analysed the different case histories and from their work the following pattern of attacks emerges (Table 25. 2):
"The attacks usually commense between the 5th and 7th years of life. The onset is sudden and, in about half of the patients, marked by a click or shock. Within a few seconds this is followed by a diffuse evolving or spreading sensation of stiffness or limpness, causing awareness of an attack without the occurrence of actual movement. The intensity peaks in a matter of seconds and subsequently declines gradually over several minutes. In addition to the characteristic incoordination, most patients notice trembling of the face, head or limbs and many report visual blurring and staring of the eyes. A minority report a feeling of warmth or increased perspiration. Nausea or rotatory vertigo and involuntary jerking or writhing movements are absent."
The attacks are frequently elicited by a sudden or unexpected movement, as in paroxysmal kinesigenic choreoathetosis. Typical triggers include rising from achair, running, or performing gymnastics or sports. During the attacks patients have disturbed limb coordination and reduced speed of alternating movements; also their gait is broad-based. Other typical signs during the attack are postural tremor of the arms and head, and dysarthria. Myokymiaparticularly in the face -may be increased.
Myokymia can be observed in some patients inbetween the attacks, but it is regularly detected by electromyography as a continuous motor unit activity with repetitive single or group discharges (duplets and multiplets) (Andermann et al. 1961; Albers et al. 1981; Brunt and van Weerden 1990) . Brunt and van Weerden (l990) were able to localise the origin of myokymia in EA-l at the peripheral nerves. Between the attacks a slight postural tremor and ataxia were found in a few of the elderly affected family members (Brunt and van Weerden 1990), but progressive cerebellar atrophy is not typical for EA-l.
